Zhen Zhang

15PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 02, 2026
Integrating clinical and genomic features to predict response to neoadjuvant therapy in microsatellite-stable rectal cancer.

|Aug 11, 2026
Comparison of Thrombocytopenia and Splenomegaly in Locally Advanced Rectal Cancer Patients Receiving Total Neoadjuvant Therapy With and Without Immunotherapy.

|Aug 09, 2026
Short-Course Radiotherapy Combined With CapeOx and PD-1 Inhibitor Following Local Excision in High-Risk Early Rectal Cancer: Study Protocol for a Prospective Phase II Trial (TORCH-LE).

|Feb 24, 2026
Segment-specific PTV margins for rectal cancer radiotherapy on the MR-Linac: characterization of rectal motion and dosimetric validation.

Wang Yang, Lei Yu, Yiwen Hu

|Sep 30, 2025
Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study.

Fan Xia, Yajie Chen, Di Zhou

|Nov 15, 2024
Adjuvant chemoradiotherapy plus PD-1 inhibitor for pN3 gastric cancer: a randomized, multicenter, Phase III trial.

Wang Yang, Menglong Zhou, Guichao Li

Pageof 3

Frequent Collaborators

2 joint publications

Hui Zhang

2 joint publications

Ji Zhu

2 joint publications

Yaqi Wang

2 joint publications

Juefeng Wan